Reporting owner

KASINGER JAMES R.

Reporting owner CIK 0001708172 · General Counsel and Secretary

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.KASINGER JAMES R.KASINGER JAMES R.KASINGER JAMES R. · October 13, 2026 · Exercise / conversion · Common SharesKASINGER JAMES R. · October 6, 2026 · Exercise / conversion · Common SharesKASINGER JAMES R. · October 13, 2025 · Exercise / conversion · Common SharesOct 13, 2025Oct 13, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 13, 2026CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion
Oct 6, 2026CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion
Oct 13, 2025CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: CRISPR Therapeutics AGCRSP · company listings
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M2,113Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: CRISPR Therapeutics AGCRSP · company listings
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M1,99013.62Value: 27,103.8Currency not specifiedView ↗
Trade: CRISPR Therapeutics AGCRSP · company listings
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M2,114Not reported *Value: Not reportedCurrency not specifiedView ↗